Fredrik Y Frejd
Fredrik Y Frejd
Professor Uppsala University
Verified email at
Cited by
Cited by
Affibody molecules: engineered proteins for therapeutic, diagnostic and biotechnological applications
J Löfblom, J Feldwisch, V Tolmachev, J Carlsson, S Ståhl, FY Frejd
FEBS letters 584 (12), 2670-2680, 2010
Enhancement of the antitumor activity of interleukin-12 by targeted delivery to neovasculature
C Halin, S Rondini, F Nilsson, A Berndt, H Kosmehl, L Zardi, D Neri
Nature biotechnology 20 (3), 264-269, 2002
Affibody molecules in biotechnological and medical applications
S Ståhl, T Gräslund, AE Karlström, FY Frejd, PÅ Nygren, J Löfblom
Trends in biotechnology 35 (8), 691-712, 2017
Targeted delivery of tissue factor to the ED-B domain of fibronectin, a marker of angiogenesis, mediates the infarction of solid tumors in mice
F Nilsson, H Kosmehl, L Zardi, D Neri
Cancer research 61 (2), 711-716, 2001
Affibody molecules as engineered protein drugs
FY Frejd, KT Kim
Experimental & molecular medicine 49 (3), e306-e306, 2017
Non-immunoglobulin based protein scaffolds
J Löfblom, FY Frejd, S Ståhl
Current opinion in biotechnology 22 (6), 843-848, 2011
Lockscreen display
F Nilsson
US Patent App. 12/472,570, 2010
Phage display selection of Affibody molecules with specific binding to the extracellular domain of the epidermal growth factor receptor
M Friedman, E Nordberg, I Höidén-Guthenberg, H Brismar, GP Adams, ...
Protein engineering, design & selection 20 (4), 189-199, 2007
[29] Design and use of phage display libraries for the selection of antibodies and enzymes
F Viti, F Nilsson, S Demartis, A Huber, D Neri
Methods in enzymology 326, 480-505, 2000
The use of phage display for the development of tumour targeting agents
F Nilsson, L Tarli, F Viti, D Neri
Advanced drug delivery reviews 43 (2-3), 165-196, 2000
Affibody molecules for epidermal growth factor receptor targeting in vivo: aspects of dimerization and labeling chemistry
V Tolmachev, M Friedman, M Sandström, TLJ Eriksson, D Rosik, M Hodik, ...
Journal of Nuclear Medicine 50 (2), 274-283, 2009
Same-day imaging using small proteins: clinical experience and translational prospects in oncology
A Krasniqi, M D’Huyvetter, N Devoogdt, FY Frejd, J Sörensen, A Orlova, ...
Journal of Nuclear Medicine 59 (6), 885-891, 2018
Cellular studies of binding, internalization and retention of a radiolabeled EGFR-binding affibody molecule
E Nordberg, M Friedman, L Göstring, GP Adams, H Brismar, FY Nilsson, ...
Nuclear medicine and biology 34 (6), 609-618, 2007
In vivo imaging of the programmed death ligand 1 by 18F PET
DEG Trotter, X Meng, P McQuade, D Rubins, M Klimas, Z Zeng, ...
Journal of Nuclear Medicine 58 (11), 1852-1857, 2017
Site-specific radiometal labeling and improved biodistribution using ABY-027, a novel HER2-targeting Affibody molecule–albumin-binding domain fusion protein
A Orlova, A Jonsson, D Rosik, H Lundqvist, M Lindborg, L Abrahmsen, ...
Journal of Nuclear Medicine 54 (6), 961-968, 2013
Combining phage and staphylococcal surface display for generation of ErbB3-specific Affibody molecules
N Kronqvist, M Malm, L Göstring, E Gunneriusson, M Nilsson, ...
Protein Engineering, Design & Selection 24 (4), 385-396, 2011
Engineering and characterization of a bispecific HER2× EGFR‐binding affibody molecule
M Friedman, S Lindström, L Ekerljung, H Andersson‐Svahn, J Carlsson, ...
Biotechnology and applied biochemistry 54 (2), 121-131, 2009
Engineered high-affinity affibody molecules targeting platelet-derived growth factor receptor β in vivo
M Lindborg, E Cortez, I Höidén-Guthenberg, E Gunneriusson, ...
Journal of molecular biology 407 (2), 298-315, 2011
Inhibiting HER3-mediated tumor cell growth with affibody molecules engineered to low picomolar affinity by position-directed error-prone PCR-like diversification
M Malm, N Kronqvist, H Lindberg, L Gudmundsdotter, T Bass, FY Frejd, ...
Plos one 8 (5), e62791, 2013
Compositions and methods for treatment of angiogenesis in pathological lesions
L Zardi, D Neri, B Carnemolla, F Nilsson, L Tarli, L Borsi, C Halin
The system can't perform the operation now. Try again later.
Articles 1–20